RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SNDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Syndax Pharmaceuticals Inc stock price up 1.04% on Monday
(Updated on Apr 29, 2024)

Sell candidate since Apr 25, 2024 Gain 3.45% PDF

The Syndax Pharmaceuticals Inc stock price gained 1.04% on the last trading day (Monday, 29th Apr 2024), rising from $21.06 to $21.28. During the last trading day the stock fluctuated 2.83% from a day low at $20.85 to a day high of $21.44. The price has been going up and down for this period, and there has been a -1.57% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 50 thousand more shares were traded than the day before. In total, 700 thousand shares were bought and sold for approximately $14.90 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.71% during the next 3 months and, with a 90% probability hold a price between $19.86 and $23.53 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SNDX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 3.86%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Syndax Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $22.27. On a fall, the stock will find some support from the short-term average at $20.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Syndax Pharmaceuticals Inc stock

Syndax Pharmaceuticals Inc finds support from accumulated volume at $20.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.590 between high and low, or 2.83%. For the last week, the stock has had daily average volatility of 3.08%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SNDX) For The Upcoming Trading Day Of Tuesday 30th

For the upcoming trading day on Tuesday, 30th we expect Syndax Pharmaceuticals Inc to open at $21.19, and during the day (based on 14 day Average True Range), to move between $20.46 and $22.10, which gives a possible trading interval of +/-$0.82 (+/-3.85%) up or down from last closing price. If Syndax Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 7.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $20.74 (2.54%) than the resistance at $21.92 (3.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Syndax Pharmaceuticals Inc stock A Buy?

Syndax Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.106 Sell Candidate Unchanged

Predicted Opening Price for Syndax Pharmaceuticals Inc of Tuesday, April 30, 2024

Fair opening price April 30, 2024 Current price
$21.19 ( 0.423%) $21.28

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SNDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.78 2.35 %
R2 21.55 1.29 %
R1 21.42 0.636 %
Current price: 21.28
Support S1 20.96 -1.48 %
S2 20.83 -2.14 %
S3 20.60 -3.20 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 24.57 15.46 %
R2 23.52 10.53 %
R1 21.92 3.01 %
Current price 21.28
Support S1 20.74 -2.54%
S2 20.49 -3.71%
S3 20.32 -4.51%

FAQ

What is the symbol for Syndax Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Syndax Pharmaceuticals Inc is SNDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Syndax Pharmaceuticals Inc Stock?
Syndax Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Syndax Pharmaceuticals Inc Stock?
Syndax Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Syndax Pharmaceuticals Inc Stock.

What's the current price of Syndax Pharmaceuticals Inc Stock?
As of the end of day on the Apr 29, 2024, the price of an Syndax Pharmaceuticals Inc (SNDX) share was $21.28.

What is the 52-week high and low for Syndax Pharmaceuticals Inc Stock?
The 52-week high for Syndax Pharmaceuticals Inc Stock is $25.34 and the 52-week low is $11.23.

What is the market capitalization of Syndax Pharmaceuticals Inc Stock?
As of the Apr 29, 2024, the market capitalization of Syndax Pharmaceuticals Inc is 1.808B.

When is the next earnings date for Syndax Pharmaceuticals Inc?
The upcoming earnings date for Syndax Pharmaceuticals Inc is May 13, 2024.
Click to get the best stock tips daily for free!

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that b... SNDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT